Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Zepbound

Recent news which mentions Zepbound

Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss

May 13, 2026

Wegovy, Zepbound Prices Drop, But Most Patients Still Can't Afford Long-Term Use: 'Coverage Is Not The Same As Access,' Says Expert

July 07, 2025

Zepbound Put Eli Lilly On Top — Now Its Next Big Move Could Supercharge The Stock

June 13, 2025

McDonald's Just Got Hammered By Weight-Loss Drugs — Twice

June 11, 2025

Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial

May 12, 2025

Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum

April 29, 2025

Eli Lilly Direct-To-Consumer Push Shouldn't Worry Distributors: JPMorgan

March 07, 2025

Weight Loss Drugs Soar While Global Obesity Rates Climb, To Hit 50% Of Adults By 2050 Says New Report

March 06, 2025

Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug

December 21, 2024

EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss

December 20, 2024

Eli Lilly's $15 Billion Buyback Faces Stiff Resistance On The Charts

December 10, 2024

Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance

December 03, 2024

Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs

November 21, 2024

Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip?

November 19, 2024

Zepbound, Mounjaro Maker Eli Lilly Climbs In Wednesday Pre-Market As Impressive 51% YTD Gain Sparks Stock Split Speculation

October 30, 2024

Eli Lilly Q3 Earnings On Deck: Stock Split Rumors Heat Up With Weight Loss Gains

October 29, 2024

Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?

October 22, 2024

Eli Lilly Aims To Expand Weight-Loss Drug Trials To Those At Risk, Not Just Overweight

October 01, 2024

Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments

September 25, 2024

Eli Lilly Pumps $800M Into Irish Operations To Meet Skyrocketing Demand For Mounjaro, Zepbound

September 12, 2024

Novo Nordisk Vs. Eli Lilly: Beyond The Weight-Loss Drug Battle

August 21, 2024

Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug

August 09, 2024

What's Going On With HIMS Shares Today?

August 01, 2024

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'

July 18, 2024

Ben & Jerry's Co-Founders Not Worried About Ozempic's Impact On Ice Cream Business: Here's Why

June 27, 2024

Eli Lilly Expands Fight Against Counterfeit Obesity Drug Zepbound With New Legal Actions

June 20, 2024

New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk

May 30, 2024

'Not Just A Weight Loss Story:' Eli Lilly CEO Thinks It's Possible To Meet BofA's $60B Revenue Projection From New Drug Launches

May 28, 2024

EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic

May 21, 2024

Eli Lilly Struggles To Keep Pace With Mounjaro, Zepbound Demand: 'Currently Unavailable' On Amazon Pharmacy

April 03, 2024

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.